Taro Pharmaceuticals USA, Inc. is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL. The Food and Drug Administration (FDA) classified this as a Class I Recall on March 4, 2020.

Phenytoin Oral Suspension USP, 125 mg/5 mL is used to treat grand mal and temporal lobe seizures. The recall was issued because the product may not mix properly when shaken, which could result in under- or overdosing.

Your health and safety are important to us. Please talk to your doctor or pharmacist if you have any questions or concerns regarding this recall.

You can also visit www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/taro-pharmaceuticals-usa-issues-voluntary-nationwide-recall-phenytoin-oral-suspension-usp-125-mg5ml for more information. You can also call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), Monday through Friday, 8 a.m. to 6:30 p.m., and Saturday 8 a.m. to 4:30 p.m., Eastern Time.